Article
Nature 442, 997-1002 (31 August 2006) | doi:10.1038/nature05010; Received 16 May 2006; Accepted 20 June 2006; Published online 20 August 2006
Mast cells are essential intermediaries in regulatory T-cell tolerance
Li-Fan Lu1, Evan F. Lind1, David C. Gondek1, Kathy A. Bennett1, Michael W. Gleeson1, Karina Pino-Lagos1, Zachary A. Scott1, Anthony J. Coyle2, Jennifer L. Reed2, Jacques Van Snick3, Terry B. Strom4, Xin Xiao Zheng4 and Randolph J. Noelle1
Abstract
Contrary to the proinflammatory role of mast cells in allergic disorders, the results obtained in this study establish that mast cells are essential in CD4+CD25+Foxp3+ regulatory T (TReg)-cell-dependent peripheral tolerance. Here we confirm that tolerant allografts, which are sustained owing to the immunosuppressive effects of TReg cells, acquire a unique genetic signature dominated by the expression of mast-cell-gene products. We also show that mast cells are crucial for allograft tolerance, through the inability to induce tolerance in mast-cell-deficient mice. High levels of interleukin (IL)-9—a mast cell growth and activation factor—are produced by activated TReg cells, and IL-9 production seems important in mast cell recruitment to, and activation in, tolerant tissue. Our data indicate that IL-9 represents the functional link through which activated TReg cells recruit and activate mast cells to mediate regional immune suppression, because neutralization of IL-9 greatly accelerates allograft rejection in tolerant mice. Finally, immunohistochemical analysis clearly demonstrates the existence of this novel TReg–IL-9–mast cell relationship within tolerant allografts.
- Department of Microbiology & Immunology, Dartmouth Medical School and the Norris Cotton Cancer Center, 1 Medical Center Drive, Lebanon, New Hampshire 03756, USA
- Department of Autoimmunity and Inflammation, MedImmune, Gaithersburg, Maryland 20878, USA
- Ludwig Institute for Cancer Research (Brussels Branch) and Experimental Medicine Unit, Université de Louvain, Brussels Branch, 74 Avenue Hippocrate, UCL 7459, B-1200 Brussels, Belgium
- Department of Medicine, Division of Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
Correspondence to: Randolph J. Noelle1 Correspondence and requests for materials should be addressed to R.J.N. (Email: rjn@dartmouth.edu).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Immunology Protection and privilegeNature News and Views (31 Aug 2006)
Research highlightsNature Immunology News and Views (01 Oct 2006)
See all 5 matches for News And ViewsRESEARCH
Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in miceNature Medicine Letter (01 Aug 2009)
See all 40 matches for Research
